HOSTDX
LIVE

Serial Number

97384900

Owner

Inflammatix, Inc.

Attorney

Stephanie Bald

Filing Date

Apr 27, 2022

Add to watchlist:

No watchlists yet
View on USPTO

HOSTDX Trademark

Serial Number: 97384900

HOSTDX is a trademark filed by Inflammatix, Inc. on April 27, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Inflammatix, Inc. (12 trademarks)

Sunnyvale, CA 94085

Entity Type: 03

Trademark Details

Filing Date

April 27, 2022

Registration Date

Not Registered

Published for Opposition

January 30, 2024

Goods & Services

Medical diagnostic services in the field of diagnostic testing services; medical diagnostic services for gene expression testing, gene expression profiling, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing biomarker levels, analyzing relative expressions of host response, analyzing clinical data, and/or analyzing demographic information

Medical and diagnostic apparatus for use in gene expression tests, gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing clinical data, and/or analyzing demographic information; medical and diagnostic apparatus for analysis of biomarker levels and/or relative expression of host response genes; medical and diagnostic apparatus for analyzing gene expression tests using bioinformatics and machine learning algorithms; medical and diagnostic apparatus for gene expression tests, gene expression profiling assays, analyzing genetic information, analyzing protein biomarkers, analyzing clinical data, and/or analyzing demographic information to aid treatment decisions

Medical research, namely, development of rapid medical tests and molecular diagnostic tests using bioinformatics, algorithms, and machine learning; development of medical tests based on the immune system and immune responses, gene expression, protein biomarker levels, genetic information, demographic information and/or clinical data, for medical purposes

Medical diagnostic reagents and assays for use in gene expression tests, gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analysis of biomarker levels and/or for use in analyzing relative expressions of host response

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 25, 2026 EXRA
SOU EXTENSION 4 GRANTED
Mar 24, 2026 EX4G
SOU EXTENSION 4 FILED
Mar 24, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 24, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2025 EXRA
SOU EXTENSION 3 GRANTED
Sep 11, 2025 EX3G
SOU EXTENSION 3 FILED
Sep 11, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 11, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 12, 2025 EXRA
SOU EXTENSION 2 GRANTED
Mar 12, 2025 EX2G
SOU EXTENSION 2 FILED
Mar 12, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 12, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 23, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 23, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 23, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 23, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 26, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2023 CRFA
ASSIGNED TO LIE
Nov 30, 2023 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 28, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 28, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 28, 2023 REAP
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 26, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 1, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 1, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 30, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 30, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 30, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 30, 2022 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 2, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 2, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 2, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 2, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 2, 2022 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 3, 2022 NWOS
NEW APPLICATION ENTERED
Apr 30, 2022 NWAP